2.1. Setting and Eligibility Criteria
Ovarian Cancer
DER, OVARIAN CANCER, BREAST
The study was conducted between 2019 and 2021 at six study centers in Germany that belong to the Familial Breast and Ovarian Cancer consortium (University Hospital of Cologne, University Hospital of Würzburg, University Hospital Schleswig-Holstein Campus Kiel, University Hospital Heidelberg, University Hospital Carl Gus-tav Carus Dresden, and University Hospital rechts der Isar Munich). Data presented in this paper were collected as part of a larger randomized controlled trial evaluating a decision support program in healthy 